Form 4 Tracker
CORCEPT THERAPEUTICS INC
CORT

84 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 7, 2025Oct 7 5:51 PMGuyer William
Proposed Sale
20,000$89.85$1.8M—

View →

Oct 1, 2025Oct 1 7:34 PMBELANOFF JOSEPH K
Proposed Sale
40,000$83.11$3.3M—

View →

Oct 1, 2025Oct 1 5:54 PMMaduck Sean
Proposed Sale
20,000$83.11$1.7M—

View →

Oct 1, 2025Oct 1 5:42 PMLyon Joseph Douglas
Proposed Sale
5,000$83.11$415.6K—

View →

Sep 10, 2025Sep 10 1:50 PMSwisher Daniel N JR
Proposed Sale
2,200$72.45$159.4K—

View →

Sep 2, 2025Sep 2 8:31 PMGuyer William
Proposed Sale
20,000$69.72$1.4M—

View →

Sep 2, 2025Sep 2 8:23 PMMaduck Sean
Proposed Sale
20,000$69.72$1.4M—

View →

Sep 2, 2025Sep 2 8:16 PMLyon Joseph Douglas
Proposed Sale
5,000$69.72$348.6K—

View →

Sep 2, 2025Sep 2 8:09 PMBELANOFF JOSEPH K
Proposed Sale
40,000$69.72$2.8M—

View →

Aug 22, 2025Aug 22 2:58 PMRobb Gary Charles
Proposed Sale
2,326$71.27$165.8K—

View →

Aug 11, 2025Aug 11 2:20 PMSwisher Daniel N JR
Proposed Sale
2,200$72.30$159.1K—

View →

Aug 5, 2025Aug 5 5:05 PMGuyer William
Proposed Sale
20,000$71.77$1.4M—

View →

Aug 1, 2025Aug 1 3:25 PMLyon Joseph Douglas
Proposed Sale
5,000$67.17$335.9K—

View →

Aug 1, 2025Aug 1 3:11 PMMaduck Sean
Proposed Sale
20,000$67.15$1.3M—

View →

Aug 1, 2025Aug 1 3:00 PMBELANOFF JOSEPH K
Proposed Sale
615$67.17$41.3K—

View →

Jul 17, 2025Jul 17 8:00 PMBELANOFF JOSEPH K
Proposed Sale
40,000$72.85$2.9M—

View →

Jul 10, 2025Jul 10 4:21 PMSwisher Daniel N JR
Proposed Sale
2,200$71.08$156.4K—

View →

Jul 1, 2025Jul 1 6:09 PMMaduck Sean
Proposed Sale
20,000$73.40$1.5M—

View →

Jul 1, 2025Jul 1 6:01 PMLyon Joseph Douglas
Proposed Sale
5,000$73.40$367.0K—

View →

Jul 1, 2025Jul 1 5:52 PMGuyer William
Proposed Sale
20,000$73.40$1.5M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 1, 2026Jul 6 8:44 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.27116,986(D)

View →

Jun 15, 2026Jun 17 8:30 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$19.2620,000(D)

View →

Jun 2, 2026Jun 4 8:49 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65150,000(D)

View →

Jun 1, 2026Jun 3 11:20 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
25,000$8.27141,986(D)

View →

Jun 1, 2026Jun 3 11:20 PMAtabak MokariChief Financial Officer
Option Exercise
40,000$19.2660,000(D)

View →

May 27, 2026May 29 10:03 PMSean MaduckPresident, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Option Exercise
75,000$8.27166,986(D)

View →

May 21, 2026May 26 9:40 PMBAKER G LEONARD JRDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:39 PMGregg H AltonDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:36 PMJames N WilsonDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:35 PMDaniel N Swisher JRDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:33 PMJoshua M. MurrayDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:31 PMDavid L MahoneyDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 21, 2026May 26 9:28 PMKimberly ParkDirector
Grant/Award
12,500$59.6912,500(D)

View →

May 5, 2026May 7 8:30 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65170,000(D)

View →

Apr 7, 2026Apr 8 11:34 PMWilliam GuyerChief Development Officer
Option Exercise
20,000$21.65190,000(D)

View →

Mar 20, 2026Mar 24 8:54 PMWilliam GuyerChief Development Officer
Option Exercise
11,767$21.65210,000(D)

View →

Mar 13, 2026Mar 17 11:52 PMDavid L MahoneyDirector
Option Exercise
30,000$5.860(D)

View →

Mar 4, 2026Mar 6 9:30 PMWilliam GuyerChief Development Officer
Option Exercise
8,233$21.65221,767(D)

View →

Feb 27, 2026Mar 3 11:19 PMJoseph Douglas LyonChief Accounting & Technology Officer
Grant/Award
140,000$35.70140,000(D)

View →

Feb 27, 2026Mar 3 11:17 PMBELANOFF JOSEPH KDirector, Chief Executive Officer
Grant/Award
460,000$35.70460,000(D)

View →